Page 138 - 《中国药房》2021年24期
P. 138

的相关性分析[J].药学实践杂志,2020,38(3):273-276.                open-label,multicentre,randomised controlled trial[J].
        [17]  周静.癫痫患者172例丙戊酸钠血药浓度分析[J].临床合                       Lancet,2019,393(10186):2135-2145.
             理用药杂志,2021,14(10):147,149.                     [31]  LYTTLE M D,RAINFORD N E A,GAMBLE C,et al.
        [18]  刘春河,邓莉,赵瑛,等. 2016-2018 年我院 856 例患者                 Levetiracetam versus phenytoin for second-line treatment
             的丙戊酸钠血药浓度监测结果分析[J].中国药房,2020,                       of paediatric convulsive status epilepticus(EcLiPSE):a
             31(3):344-348.                                      multicentre,open-label,randomised trial[J]. Lancet,2019,
        [19]  王胜泉,周辉.左乙拉西坦对癫痫患儿性激素和甲状腺激                          393(10186):2125-2134.
             素的影响[J].中国药房,2017,28(35):4970-4974.            [32]  HANDRAL A,VEERAPPA B G,GOWDA V K,et al.
        [20]  陈仁海,邓轶方,黄晓玲,等.左乙拉西坦缓释片的处方及                         Levetiracetam versus fosphenytoin in pediatric convulsive
             制备工艺研究[J].中国新药杂志,2015,24(12):1427-                  status epilepticus:a randomized controlled trial[J]. J Pe-
             1434.                                               diatr Neurosci,2020,15(3):252-256.
        [21]  REINDL C,SPRÜGEL M I,SEMBILL J A,et al. In-   [33]  VIGNESH V,RAMESHKUMAR R,MAHADEVAN S.
             fluence of new versus traditional antiepileptic drugs on  Comparison of phenytoin,valproate and levetiracetam in
             course and outcome of status epilepticus[J]. Seizure,  pediatric convulsive status epilepticus:a randomized dou-
             2020,74:20-25.                                      ble-blind controlled clinical trial[J]. Indian Pediatr,2020,
        [22]  夏毅,张伟,井晓蓉,等.儿童癫痫持续状态的临床特点、                         57(3):222-227.
             治疗及预后分析[J].中华神经外科杂志,2021,37(1):                [34]  NAKAMURA K,OHBE H,MATSUI H,et al. Levetirace-
             16-20.                                              tam vs. fosphenytoin for second-line treatment of status
        [23]  张群群,刘灵芝,金志鹏,等.儿童癫痫持续状态的临床特                         epilepticus:propensity score matching analysis using a na-
             点及预后影响因素分析[J].重庆医学,2020,49(23):                     tionwide inpatient database[J]. Front Neurol,2020,11:
             3931-3935.                                          615.
        [24]  MARTINOS M M,PUJAR S,O’REILLY H,et al. Intelli-  [35]  CHAKRAVARTHI S,GOYAL M K,MODI M,et al. Leve-
             gence and memory outcomes within 10 years of childhood  tiracetam versus phenytoin in management of status epi-
             convulsive status epilepticus[J]. Epilepsy Behav,2019,  lepticus[J]. J Clin Neurosci,2015,22(6):959-963.
             95:18-25.                                      [36]  GUJJAR A R,NANDHAGOPAL R,JACOB P C,et al. In-
        [25]  NOUREEN N,KHAN S,KHURSHEED A,et al. Clinical       travenous levetiracetam vs phenytoin for status epilepticus
             efficacy and safety of injectable levetiracetam versus  and cluster seizures:a prospective,randomized study[J].
             phenytoin as second-line therapy in the management of  Seizure,2017,49:8-12.
             generalized convulsive status epilepticus in children:an  [37]  ALVAREZ V,JANUEL J M,BURNAND B,et al. Se-
             open-label randomized controlled trial[J]. J Clin Neurol,  cond-line status epilepticus treatment:comparison of
             2019,15(4):468-472.                                 phenytoin,valproate,and levetiracetam[J]. Epilepsia,
        [26]  WANI G,IMRAN A,DHAWAN N,et al. Levetiracetam       2011,52(7):1292-1296.
             versus phenytoin in children with status epilepticus[J]. J  [38]  MUNDLAMURI R C,SINHA S,SUBBAKRISHNA D K,
             Family Med Prim Care,2019,8(10):3367-3371.          et al. Management of generalised convulsive status epilep-
        [27]  NALISETTY S,KANDASAMY S,SRIDHARAN B,               ticus(SE):a prospective randomised controlled study of
             et al. Clinical effectiveness of levetiracetam compared to  combined treatment with intravenous lorazepam with ei-
             fosphenytoin in the treatment of benzodiazepine refrac-  ther phenytoin,sodium valproate or levetiracetam:pilot
             tory convulsive status epilepticus[J]. Indian J Pediatr,  study[J]. Epilepsy Res,2015,114:52-58.
             2020,87(7):512-519.                            [39]  CHAMBERLAIN J M,KAPUR J,SHINNAR S,et al.
        [28]  BESLI G E,YUKSEL KARATOPRAK E,YILMAZ S.            Efficacy of levetiracetam,fosphenytoin,and valproate for
             Efficacy and safety profile of intravenous levetiracetam  established status epilepticus by age group(ESETT):a
             versus phenytoin in convulsive status epilepticus and  double-blind,responsive-adaptive,randomised controlled
             acute repetitive seizures in children[J]. Epilepsy Behav,  trial[J]. Lancet,2020,395(10231):1217-1224.
             2020,111:107289.                               [40]  NENE D,MUNDLAMURI R C,SATISHCHANDRA P,
        [29]  SINGH K,AGGARWAL A,FARIDI M M A,et al. Ⅳ           et al. Comparing the efficacy of sodium valproate and
             levetiracetam versus Ⅳ phenytoin in childhood seizures:a  levetiracetam following initial lorazepam in elderly
             randomized controlled trial[J]. J Pediatr Neurosci,2018,  patients with generalized convulsive status epilepticus
             13(2):158-164.                                     (GCSE):a prospective randomized controlled pilot
        [30]  DALZIEL S R,BORLAND M L,FURYK J,et al. Leveti-     study[J]. Seizure,2019,65:111-117.
             racetam versus phenytoin for second-line treatment of con-   (收稿日期:2021-06-25  修回日期:2021-11-26)
             vulsive status epilepticus in children(ConSEPT):an                                  (编辑:孙   冰)


        ·3072 ·  China Pharmacy 2021 Vol. 32 No. 24                                 中国药房    2021年第32卷第24期
   133   134   135   136   137   138   139   140   141   142   143